New insight into the key proteins and pathways involved in the metastasis of colorectal carcinoma

Oncology Reports

Volumn 19, Issue 5, 2008, Pages 1191-1204

  Yu, Guan Zhen ^a   Chen, Ying ^a   Long, Ya Qiu ^b   Dong, Dong ^c   Mu, Xiao Lan ^d   Wang, Jie Jun ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c Key Laboratory of Health and Disease Genomics   (China)

^d Genminix Informatics Ltd Co   (China)

Author keywords

Colorectal carcinoma; Metastasis; Pathway

Indexed keywords

CALVASCULIN; COMPLEMENTARY DNA; EPHRIN RECEPTOR B2; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; KRT20 PROTEIN; METASTIN; PROTEIN SH2; TUMOR MARKER; UNCLASSIFIED DRUG; GRB2 PROTEIN, HUMAN; GRB2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL MOTILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; TUMOR GROWTH; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CARCINOMA; COLORECTAL TUMOR; GENE EXPRESSION PROFILING; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; CARCINOMA; COLORECTAL NEOPLASMS; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GRB2 ADAPTOR PROTEIN; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION;

EID: 47549093954     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.19.5.1191     Document Type: Article

References (29)

1. Debies MT and Welch DR: Genetic basis of human breast cancer metastasis. J Mamm Gland Biol Neopl 6: 441-451, 2002.
2. Martin MD, Fischbach K, Osborne CK, Mohsin SK, Allred DC and O'Connell P: Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene. Cancer Res 61: 3578-3580, 2001.
3. Ornstein DK, Gillespie JW, Paweletz CP, Duray PH, Herring J, Vocke CD, Topalian SL, Bostwick DG, Linehan WM, Petricoin EF III and Emmert-Buck MR: Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 21: 2235-2242, 2000.
4. Sugiyama Y, Farrow B, Murillo C, Li J, Watanabe H, Sugiyama K and Evers BM: Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues. Gastroenterology 128: 480-486, 2005.
5. Yu GZ, Zhu MH, Zhu Z, Ni CR, Zheng JM and Li FM: Expression of ATM protein and its relationship with p53 in pancreatic carcinoma with tissue array. Pancreas 28: 421-426, 2004.
6. Song YL, Roller PP and Long YQ: Development of 1-3- aminotyrosine suitably protected for the synthesis of a novel nonphosphorylated hexapeptide with low-nanomolar Grb2-SH2 domain-binding affinity. Bioorg Med Chem Lett 14: 3205-3208, 2004.
7. Toh Y, Pencil SD and Nicolson GL: A novel candidate metastasis-associated gene, nital, differentially expressed in highly metastatic mammary adenocarcinoma. cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269: 22958-22963, 1994.
8. Dbar DK, Naora H, Kubota H, Maruyama R, Yoshimura H, Tonomoto Y, Tachibana M, Ono T, Otani H and Nagasue N: Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. Int J Cancer 111: 868-872, 2004.
9. Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M and Ushijima T: Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 97: 64-71, 2006.
10. Belot N, Pochet R, Heizmann CW, Kiss R and Decaestecker C: Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton. Biochim Biophys Acta 1600: 74-83, 2002.
11. Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, Bjornland K, Fodstad O and Maelandsmo GM: Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer. J Patbol 200: 589-595, 2003.
12. Okazaki H, Mizuno M, Nasu J, Makidono C, Hiraoka S, Yamamoto K, Okada H, Fujita T, Tsuji T and Shiratori Y: Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis. J Lab Clin Med 143: 169-174, 2004.
13. Nowicki S, Nowicki B, Pham T, Hasan R and Nagamani M: Expression of decay accelerating factor in endometrial adenocarcinoma is inversely related to the stage of tumor. Am J Reprod Inummol 46: 144-148, 2001.
14. Sobel G, Paska C, Szabo I, Kiss A, Kadar A and Schaff Z: Increased expression of claudins in cervical squamous intraepithelial neoplasia and invasive carcinoma. Hum Pathol 36: 162-169, 2005.
15. Kivela AJ, Parkkila S, Saarnio J, Karttunen TJ, Kivela J, Parkkila AK, Bartosova M, Mucha V, Novak M, Waheed A, Sly WS, Rajaniemi H, Pastorekova S and Pastorek J: Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa. World J Gastroenterol 11: 2616-2625, 2005.
16. Gu C, Oyama T, Osaki T, Li J, Takenoyama M, Izumi H, Sugio K, Kohno K and Yasumoto K: Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. Br J Cancer 90: 436-442, 2004.
17. Matsui A, Ikeda T, Enomoto K, Nakashima H, Omae K, Watanabe M, Hibi T and Kitajima M: Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-O-methyltransferase. Cancer Lett 150: 23-31, 2000.
18. Liu SH, Lin CY, Peng SY, Jeng YM, Pan HW, Lai PL, Liu CL and Hsu HC: Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol 160:1831-1837, 2002.
19. Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C and Rodrigo JP: Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 164: 73-79, 2004.
20. Guo DL, Zhang J, Yuen ST, Tsui WY, Chan AS, Ho C, Ji J, Leung SY and Chen X: Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumors. Carcinogenesis 27: 454-464, 2006.
21. Frederiksen CM, Knudsen S, Laurberg S and Ontoft TF: Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol 129: 263-271, 2003.
22. Saucier C, Papavasiliou V, Palazzo A, Naujokas MA, Kremer R and Park M: Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis. Oncogene 21: 1800-1811, 2002.
23. Rouer E: Expression of the p561ck by colon tumors: a marker of their invasive capacity? Bull Cancer 91: 928-940, 2004.
24. Xia G, Kumar SR, Stein JP, Singh J, Krasnoperov V, Zhu S, Hassanieh L, Smith DL, Buscarini M, Brock D, Quinn DI, Weaver FA and Gill PS: EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene 25: 769-780, 2006.
25. Tamai S, Masuda H, Ishii Y, Suzuki S, Kanai Y and Endou H: Expression of L-type amino acid transporter 1 in a rat model of liver metastasis: positive correlation with tumor size. Cancer Detect Prev 25: 439-445, 2001.
26. Sticht C, Hofele C, Flechtenmacher C, Bosch FX, Freier K, Lichter P and Joos S: Amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC). Br J Cancer 92: 770-774, 2005.
27. Oh-e H, Tanaka S, Kitadai Y, Shimamoto F, Yoshihara M and Haruma K: Cathepsin D expression as a possible predictor of lymph node metastasis in submucosal colorectal cancer. Eur J Cancer 37: 180-188, 2001.
28. Yang S, Zhong C, Frenkel B, Reddi AH and Roy-Burman P: Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells. Cancer Res 65: 5769-5777, 2005.
29. Dharmawardana PG, Peruzzi B, Giubellino A, Burke TR Jr and Bottaro DP: Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy. Anticancer Drugs 17: 13-20, 2006.